Literature DB >> 9800049

Angina pectoris in a contemporary population: characteristics and therapeutic implications. TIDES Investigators.

C J Pepine1.   

Abstract

We characterized a contemporary, nonhospitalized population with angina pectoris by obtaining data from a geographically diverse cohort of 5125 outpatients with chronic stable angina cared for by 1266 primary-care physicians. Diagnosis was based on history supported by evidence for coronary artery disease (coronary angiography, old myocardial infarction [MI], and/or an abnormal stress test). Their mean age was 69 years and 53% were women. Seventy percent had more than one associated illness, and 65% used more than one cardiovascular drug. Calcium antagonists (46%) and nitrates (61%) were used most frequently. Median angina frequency was approximately 2 episodes/week, and increased angina frequency was associated (P < 0.0001) with decreased overall feeling of well-being. Although effort angina was present in 90% of patients, 47% also had rest angina and 34% had mental stress-evoked angina. Female gender (odds ratio: 1.09; 95% CI: 1.02-1.16), concomitant illness (1.17, 1.09-1.25), and pharmacotherapy (1.14, 1.07-1.22) were associated with rest angina. Younger age (1.30, 1.20-1.41), female gender (1.16, 1.07-1.26), concomitant illness (1.13, 1.03-1.24), and pharmacotherapy (1.28, 1.15-1.93) were associated with mental stress angina. Calcium antagonists were used for rest-evoked (1.09, 1.03-1.16) and mental stress-evoked (1.12, 1.04-1.21) angina. These data suggest that contemporary outpatients with angina are most likely to be women and elderly patients with high frequencies of associated illness, calcium antagonist and nitrate use, as well as rest- and mental stress-related angina. These characteristics differ from previous perceptions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9800049     DOI: 10.1023/a:1017193011667

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  4 in total

1.  Ivabradine: the evidence of its therapeutic impact in angina.

Authors:  Guillaume Marquis-Gravel; Jean-Claude Tardif
Journal:  Core Evid       Date:  2008-06

2.  The impact of diabetes on one-year health status outcomes following acute coronary syndromes.

Authors:  Pamela N Peterson; John A Spertus; David J Magid; Fredrick A Masoudi; Kimberly Reid; Richard F Hamman; John S Rumsfeld
Journal:  BMC Cardiovasc Disord       Date:  2006-10-24       Impact factor: 2.298

3.  Gender- and age-related differences in treatment and control of cardiovascular risk factors among high-risk patients with angina.

Authors:  Katherine H Hendrix; Susan Mayhan; Brent M Egan
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-07       Impact factor: 3.738

4.  A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve.

Authors:  C Noel Bairey Merz; Eileen M Handberg; Chrisandra L Shufelt; Puja K Mehta; Margo B Minissian; Janet Wei; Louise E J Thomson; Daniel S Berman; Leslee J Shaw; John W Petersen; Garrett H Brown; R David Anderson; Jonathan J Shuster; Galen Cook-Wiens; André Rogatko; Carl J Pepine
Journal:  Eur Heart J       Date:  2015-11-27       Impact factor: 35.855

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.